Name:	O
___	O
Unit	O
No:	O
___	O
Admission	O
Date:	O
___	O
Discharge	O
Date:	O
___	O
Date	O
of	O
Birth:	O
___	O
Sex:	O
M	O
Service:	O
MEDICINE	O
Allergies:	O
Penicillins	O
/	O
Lamictal	O
/	O
Bactrim	O
/	O
Levaquin	O
Attending:	O
___.	O
Chief	O
Complaint:	O
weakness	O
Major	O
Surgical	O
or	O
Invasive	O
Procedure:	O
Anterior	O
cervical	O
discectomy	O
and	O
fusion	O
(ACDF)	O
c3-c6	O
-	O
___	O
Perc	O
G	O
tube	O
placement	O
___	O
History	O
of	O
Present	O
Illness:	O
Mr.	O
___	O
is	O
a	O
___	O
y/o	O
male	O
with	O
a	O
history	O
of	O
severe	O
cervical	O
stenosis	O
s/p	O
C3-C7	O
posterior	O
cervical	O
laminectomy/fusion	O
(___),	O
ESRD	O
s/p	O
renal	O
transplant	O
(___),	O
HTN,	O
DM,	O
seizures,	B-Seizures
and	O
OSA	O
who	O
presents	O
with	O
AMS	B-Delirium
and	O
weakness.	O
The	O
patient	O
has	O
a	O
history	O
of	O
progressive	O
gait	O
ataxia,	O
leg	O
stiffness,	O
and	O
recurrent	O
falls,	B-Falls
which	O
ultimately	O
led	O
to	O
a	O
C1	O
and	O
C3	O
fracture.	O
He	O
then	O
had	O
an	O
MRI	O
showing	O
severe	O
cervical	O
stenosis	O
from	O
C3-C7.	O
He	O
was	O
admitted	O
to	O
___	O
from	O
___	O
for	O
C3-C7	O
laminectomy/fusion.	O
His	O
post-op	O
course	O
was	O
complicated	O
by	O
upper	O
extremity	O
paresis	O
with	O
work	O
up	O
revealing	O
a	O
large	O
seroma	O
with	O
abnormal	O
cord	O
signal	O
at	O
C5-C7.	O
___	O
was	O
consulted	O
and	O
drained	O
one	O
of	O
the	O
two	O
fluid	O
collections	O
with	O
improvement	O
in	O
his	O
symptoms.	O
He	O
was	O
discharged	O
to	O
rehab,	O
where	O
his	O
strength	O
remained	O
stable.	O
Notably	O
his	O
wife	O
reports	O
he	O
was	O
able	O
to	O
use	O
his	O
right	O
arm	O
moderately	O
well,	O
minimal	O
use	O
of	O
his	O
left	O
arm,	O
and	O
moderate	O
BLE	O
strength,	O
able	O
to	O
walk	O
a	O
few	O
steps.	O
He	O
was	O
at	O
his	O
baseline	O
until	O
yesterday	O
when	O
his	O
wife	O
checked	O
on	O
him	O
in	O
the	O
afternoon	O
and	O
found	O
him	O
slouched	O
over	O
in	O
a	O
wheelchair	B-Mobile_with_aid
with	O
his	O
chin	O
to	O
his	O
chest,	O
without	O
his	O
C-collar	O
in	O
place.	O
She	O
reports	O
he	O
had	O
minimal	O
responsiveness	O
for	O
___	O
minutes.	O
He	O
reportedly	O
had	O
no	O
seizure-like	B-Seizures
activity,	O
tongue	O
biting	O
or	O
incontinence	B-Urinary_incontinence
but	O
it	O
took	O
a	O
while	O
for	O
him	O
to	O
come	O
to.	O
He	O
was	O
also	O
cold	O
and	O
was	O
foaming	O
at	O
the	O
mouth	O
per	O
his	O
wife.	O
EMS	O
was	O
called	O
and	O
he	O
was	O
transferred	O
to	O
___,	O
where	O
he	O
was	O
found	O
to	O
be	O
hemodynamically	O
stable.	O
Labs	O
were	O
notable	O
for	O
WBC	O
8,	O
Cr	O
2,	O
and	O
CT	O
head	O
showed	O
no	O
acute	O
intracranial	O
process.	O
CT	O
C-spine	O
revealed	O
severe	O
disc	O
space	O
narrowing	O
at	O
C3-C4,	O
moderate	O
to	O
severe	O
disc	O
space	O
narrowing	O
at	O
C4-C5,	O
and	O
moderate	O
disc	O
space	O
narrowing	O
at	O
C5-C6	O
and	O
C6-C7.	O
He	O
was	O
transferred	O
to	O
___	O
for	O
further	O
management.	O
In	O
the	O
ED,	O
initial	O
vitals:	O
Temp	O
97.7F	O
BP	O
118/55	O
HR	O
73	O
RR	O
16	O
98%	O
on	O
RA	O
Exam:	O
C-collar	O
in	O
place,	O
rigid	O
RUE	O
with	O
PROM,	O
smooth	O
movement	O
with	O
PROM,	O
___	O
strength	O
throughout	O
BLE,	O
normal	O
sensation,	O
no	O
rectal	O
tone	O
Labs	O
were	O
significant	O
for:	O
K	O
5.5	O
->	O
4.3,	O
Cr	O
2.0,	O
AG	O
20,	O
trop	O
0.05->0.06,	O
CK	O
489,	O
serum/urine	O
tox	O
negative,	O
UA	O
negative	O
Imaging	O
showed:	O
-	O
MRI	O
spine	O
showed	O
cord	O
or	O
cauda	O
equina	O
compression	O
at	O
multiple	O
levels,	O
most	O
severe	O
at	O
C5-C6	O
In	O
the	O
ED,	O
pt	O
received:	O
___	O
01:18	O
IV	O
LORazepam	O
1	O
mg	O
___	O
01:48	O
IV	O
LORazepam	O
.5	O
mg	O
___	O
06:37	O
IVF	O
NS	O
1000	O
mL	O
___	O
08:52	O
PO	O
Tacrolimus	O
1.5	O
mg	O
___	O
12:07	O
IVF	O
NS	O
___	O
Started	O
250	O
mL/hr	O
x	O
1	O
liter	O
Consults:	O
-	O
Neurology:	O
recommended	O
ortho	O
spine	O
consult	O
and	O
bladder	O
scans	O
-	O
Spine	O
surgery:	O
maintain	O
hard	O
collar,	O
foley	O
catheter,	O
NPO,	O
possible	O
OR	O
today,	O
admission	O
to	O
medicine	O
-	O
Renal:	O
give	O
IV	O
fluid	O
for	O
___	O
Vitals	O
prior	O
to	O
transfer:	O
Temp	O
98.1F	O
BP	O
132/53	O
HR	O
71	O
RR	O
13	O
100%	O
on	O
RA	O
On	O
the	O
floor,	O
the	O
patient	O
reports	O
diffuse	O
weakness,	O
most	O
prominent	O
over	O
his	O
upper	O
extremities.	O
He	O
also	O
reports	O
neck	O
pain	O
and	O
recent	O
urinary	B-Urinary_tract_infection
incontinence,	B-Urinary_tract_infection
unsure	O
of	O
bowel	B-Faecal_incontinence
incontinence.	B-Faecal_incontinence
He	O
is	O
unsure	O
of	O
the	O
events	O
that	O
occurred	O
yesterday.	O
He	O
notes	O
that	O
he	O
typically	O
wears	O
his	O
c-collar	O
any	O
time	O
he	O
is	O
not	O
sleeping.	O
He	O
denies	O
any	O
recent	O
fever,	O
chills,	O
abdominal	O
pain,	O
nausea,	O
or	O
vomiting.	O
Of	O
note,	O
the	O
patient's	O
wife	O
reports	O
that	O
he	O
has	O
had	O
progressive	O
weakness	O
over	O
the	O
last	O
several	O
days.	O
Past	O
Medical	O
History:	O
-	O
Kidney	O
transplant	O
in	O
___,	O
last	O
Cr	O
1.5-1.6	O
-	O
DM	O
type	O
2,	O
insulin	O
dependent	O
-	O
HTN	O
-	O
Seizures	B-Seizures
-	O
Spinal	O
Cord	O
Compression	O
s/p	O
C3-C7	O
posterior	O
cervical	O
laminectomy/fusion	O
(___)	O
-	O
Sleep	O
Apnea	O
(does	O
not	O
tolerate	O
CPAP)	O
-	O
Chronic	O
Right	O
Shoulder	O
Pain	O
-	O
Asthma	O
-	O
Depressive	O
Disorder	O
in	O
remission.	O
-	O
GERD	O
-	O
RLS	O
Social	O
History:	O
___	O
Family	O
History:	O
Non-contributory	O
Physical	O
Exam:	O
ADMISSION	O
PHYSICAL	O
EXAM:	O
========================	O
VS:	O
Temp	O
98.6	O
BP	O
144/65	O
HR	O
76	O
RR	O
18	O
98%	O
on	O
RA	O
GEN:	O
Ill	O
appearing	O
male	O
in	O
NAD.	O
Lying	O
comfortably	O
in	O
bed.	O
HEENT:	O
NC/AT.	O
Anicteric	O
sclerae,	O
no	O
conjunctival	O
pallor.	O
Dry	O
MMM	O
with	O
cracked	O
lips.	O
Poor	O
dentition.	O
NECK:	O
C-collar	O
in	O
place.	O
CV:	O
RRR	O
with	O
normal	O
S1	O
and	O
S2.	O
No	O
murmurs,	O
rubs	O
or	O
gallops.	O
PULM:	O
Normal	O
respiratory	O
effort.	O
CTAB	O
without	O
wheezes,	O
rales	O
or	O
rhonchi	O
over	O
the	O
anterior	O
chest.	O
ABD:	O
Soft,	O
non-tender,	O
non-distended.	O
Normoactive	O
BS.	O
No	O
guarding	O
or	O
masses.	O
EXTREM:	O
Warm,	O
well-perfused,	O
no	O
edema	O
or	O
erythema.	O
2+	O
DP	O
pulses.	O
NEURO:	O
Alert	O
and	O
oriented	B-Delirium
x3.	B-Delirium
Able	O
to	O
do	O
days	O
of	O
the	O
week	O
backwards.	O
CN	O
II-XII	O
intact.	O
___	O
strength	O
in	O
BUE.	O
Rigidity	O
in	O
RUE,	O
flaccid	O
movement	O
in	O
LUE.	O
Able	O
to	O
move	O
fingers,	O
unable	O
to	O
squeeze.	O
___	O
strength	O
in	O
BLE.	O
Normal	O
sensation	O
throughout.	O
DISCHARGE	O
PHYSICAL	O
EXAM:	O
========================	O
97.6	O
PO	O
144	O
/	O
62	O
R	O
Lying	O
67	O
18	O
97	O
Ra	O
GEN:	O
Chronically	O
ill	O
appearing	O
male.	O
NAD.	O
Lying	O
in	O
bed	O
with	O
dobhoff	O
in	O
place.	O
HEENT:	O
NC/AT.	O
Anicteric	O
sclerae,	O
no	O
conjunctival	O
pallor.	O
Dry	O
MMM	O
with	O
cracked	O
lips.	O
Poor	O
dentition.	O
Dobhoff	O
in	O
place	O
in	O
right	O
nare.	O
NECK:	O
No	O
JVP	O
elevation.	O
Below	O
level	O
of	O
clavicle	O
at	O
60	O
degrees.	O
CV:	O
RRR	O
with	O
normal	O
S1	O
and	O
S2.	O
No	O
murmurs,	O
rubs	O
or	O
gallops.	O
PULM:	O
Normal	O
respiratory	O
effort.	O
CTAB	O
without	O
wheezes,	O
rales	O
or	O
rhonchi	O
over	O
the	O
anterior	O
chest.	O
ABD:	O
Soft,	O
mildly	O
distended.	O
nontender	O
to	O
palpation	O
Normoactive	O
BS.	O
No	O
guarding	O
or	O
masses.	O
G-tube	O
without	O
bleeding	O
or	O
tenderness	O
to	O
palpation.	O
Incision	O
c/d/i.	O
EXTREM:	O
Warm,	O
well-perfused,	O
no	O
edema	O
or	O
erythema.	O
NEURO:	O
Grossly	O
oriented	O
and	O
answering	O
questions	O
appropriately.	O
Moves	O
b/l	O
lower	O
extremity	O
to	O
command.	O
A&O	B-Delirium
x3.	B-Delirium
Pertinent	O
Results:	O
ADMISSION	O
LABS:	O
================	O
___	O
02:18AM	O
BLOOD	O
WBC-7.9	O
RBC-3.37*	O
Hgb-11.1*	O
Hct-32.4*	O
MCV-96	O
MCH-32.9*	O
MCHC-34.3	O
RDW-12.5	O
RDWSD-44.5	O
Plt	O
___	O
___	O
02:18AM	O
BLOOD	O
Neuts-64.4	O
___	O
Monos-6.4	O
Eos-0.8*	O
Baso-0.3	O
Im	O
___	O
AbsNeut-5.07	O
AbsLymp-2.14	O
AbsMono-0.50	O
AbsEos-0.06	O
AbsBaso-0.02	O
___	O
12:05AM	O
BLOOD	O
Glucose-91	O
UreaN-46*	O
Creat-2.0*	O
Na-146	O
K-5.5*	O
Cl-113*	O
HCO3-13*	O
AnGap-20*	O
___	O
12:05AM	O
BLOOD	O
ALT-14	O
AST-28	O
CK(CPK)-489*	O
AlkPhos-92	O
TotBili-0.4	O
___	O
12:05AM	O
BLOOD	O
CK-MB-14*	O
MB	O
Indx-2.9	O
cTropnT-0.05*	O
PERTINENT	O
LABS:	O
===============	O
___	O
12:05AM	O
BLOOD	O
Glucose-91	O
UreaN-46*	O
Creat-2.0*	O
Na-146	O
K-5.5*	O
Cl-113*	O
HCO3-13*	O
AnGap-20*	O
___	O
01:51AM	O
BLOOD	O
Glucose-113*	O
UreaN-35*	O
Creat-1.4*	O
Na-145	O
K-5.0	O
Cl-116*	O
HCO3-16*	O
AnGap-13	O
___	O
08:10AM	O
BLOOD	O
Glucose-298*	O
UreaN-25*	O
Creat-1.2	O
Na-139	O
K-5.5*	O
Cl-105	O
HCO3-19*	O
AnGap-15	O
___	O
12:05AM	O
BLOOD	O
ALT-14	O
AST-28	O
CK(CPK)-489*	O
AlkPhos-92	O
TotBili-0.4	O
___	O
06:38AM	O
BLOOD	O
CK(CPK)-399*	O
___	O
12:10PM	O
BLOOD	O
CK(CPK)-318	O
___	O
08:10AM	O
BLOOD	O
CK(CPK)-115	O
___	O
12:05AM	O
BLOOD	O
CK-MB-14*	O
MB	O
Indx-2.9	O
cTropnT-0.05*	O
___	O
06:38AM	O
BLOOD	O
cTropnT-0.06*	O
___	O
12:05AM	O
BLOOD	O
ASA-NEG	O
Ethanol-NEG	O
Acetmnp-NEG	O
Tricycl-NEG	O
___	O
08:40AM	O
BLOOD	O
tacroFK-15.0	O
___	O
08:10AM	O
BLOOD	O
tacroFK-17.1	O
___	O
07:23AM	O
BLOOD	O
tacroFK-8.0	O
___	O
07:38AM	O
BLOOD	O
tacroFK-5.9	O
___	O
06:13AM	O
BLOOD	O
tacroFK-6.7	O
___	O
09:21AM	O
BLOOD	O
tacroFK-4.5	O
___	O
07:15AM	O
BLOOD	O
Ret	O
Aut-1.4	O
Abs	O
Ret-0.04	O
___	O
07:10AM	O
BLOOD	O
Ret	O
Aut-3.7*	O
Abs	O
Ret-0.10	O
___	O
06:29AM	O
BLOOD	O
___	O
___	O
06:29AM	O
BLOOD	O
Glucose-195*	O
UreaN-20	O
Creat-1.5*	O
Na-137	O
K-4.1	O
Cl-102	O
HCO3-18*	O
AnGap-17	O
___	O
09:55AM	O
BLOOD	O
Glucose-220*	O
UreaN-23*	O
Creat-1.6*	O
Na-135	O
K-4.4	O
Cl-102	O
HCO3-15*	O
AnGap-18	O
___	O
05:00AM	O
BLOOD	O
Glucose-176*	O
UreaN-30*	O
Creat-1.5*	O
Na-138	O
K-4.0	O
Cl-106	O
HCO3-20*	O
AnGap-12	O
___	O
07:34AM	O
BLOOD	O
Glucose-230*	O
UreaN-30*	O
Creat-1.2	O
Na-138	O
K-3.9	O
Cl-103	O
HCO3-20*	O
AnGap-15	O
___	O
06:29AM	O
BLOOD	O
ALT-7	O
AST-16	O
LD(LDH)-267*	O
AlkPhos-128	O
TotBili-0.2	O
___	O
09:55AM	O
BLOOD	O
Hapto-237*	O
___	O
07:15AM	O
BLOOD	O
calTIBC-172*	O
Hapto-281*	O
Ferritn-186	O
TRF-132*	O
___	O
07:33AM	O
BLOOD	O
VitB12-1113*	O
Folate-10	O
___	O
04:05PM	O
BLOOD	O
CMV	O
VL-DETECTED	O
___	O
07:40AM	O
BLOOD	O
CMV	O
VL-DETECTED	O
___	O
12:33PM	O
URINE	O
Blood-SM*	O
Nitrite-POS*	O
Protein-30*	O
Glucose-NEG	O
Ketone-NEG	O
Bilirub-NEG	O
Urobiln-NEG	O
pH-6.5	O
Leuks-LG*	O
___	O
09:55AM	O
URINE	O
Blood-MOD*	O
Nitrite-NEG	O
Protein-30*	O
Glucose-NEG	O
Ketone-NEG	O
Bilirub-NEG	O
Urobiln-NEG	O
pH-6.0	O
Leuks-LG*	O
___	O
01:00PM	O
URINE	O
Blood-MOD*	O
Nitrite-NEG	O
Protein-30*	O
Glucose-NEG	O
Ketone-NEG	O
Bilirub-NEG	O
Urobiln-NEG	O
pH-7.0	O
Leuks-LG*	O
___	O
12:33PM	O
URINE	O
RBC-4*	O
WBC-90*	O
Bacteri-MOD*	O
Yeast-NONE	O
Epi-0	O
___	O
09:55AM	O
URINE	O
RBC-4*	O
WBC-47*	O
Bacteri-FEW*	O
Yeast-NONE	O
Epi-0	O
___	O
01:00PM	O
URINE	O
RBC-8*	O
WBC-103*	O
Bacteri-FEW*	O
Yeast-NONE	O
Epi-0	O
___	O
12:02	O
pm	O
STOOL	O
CONSISTENCY:	O
NOT	O
APPLICABLE	O
Source:	O
Stool.	O
**FINAL	O
REPORT	O
___	O
C.	O
difficile	O
PCR	O
(Final	O
___:	O
Reported	O
to	O
and	O
read	O
back	O
by	O
___	O
___	O
2:20PM.	O
POSITIVE.	O
(Reference	O
Range-Negative).	O
The	O
C.	O
difficile	O
PCR	O
is	O
highly	O
sensitive	O
for	O
toxigenic	O
strains	O
of	O
C.	O
difficile	O
and	O
detects	O
both	O
C.	O
difficile	O
infection	O
(CDI)	O
and	O
asymptomatic	O
carriage.	O
Therefore,	O
positive	O
C.	O
diff	O
PCR	O
tests	O
trigger	O
reflex	O
C.	O
difficile	O
toxin	O
testing,	O
which	O
is	O
highly	O
specific	O
for	O
CDI.	O
C.	O
difficile	O
Toxin	O
antigen	O
assay	O
(Final	O
___:	O
POSITIVE.	O
(Reference	O
Range-Negative).	O
PERFORMED	O
BY	O
___.	O
This	O
result	O
indicates	O
a	O
high	O
likelihood	O
of	O
C.	O
difficile	O
infection	O
(CDI).	O
___	O
3:27	O
pm	O
BLOOD	O
CULTURE	O
**FINAL	O
REPORT	O
___	O
Blood	O
Culture,	O
Routine	O
(Final	O
___:	O
ESCHERICHIA	O
COLI.	O
Identification	O
and	O
susceptibility	O
testing	O
performed	O
on	O
culture	O
#	O
___	O
(___).	O
ESCHERICHIA	O
COLI.	O
___	O
MORPHOLOGY.	O
Identification	O
and	O
susceptibility	O
testing	O
performed	O
on	O
culture	O
#	O
___	O
___.	O
Anaerobic	O
Bottle	O
Gram	O
Stain	O
(Final	O
___:	O
GRAM	O
NEGATIVE	O
ROD(S).	O
___	O
12:33	O
pm	O
URINE	O
Source:	O
___.	O
**FINAL	O
REPORT	O
___	O
URINE	O
CULTURE	O
(Final	O
___:	O
ESCHERICHIA	O
COLI.	O
>100,000	O
CFU/mL.	O
Cefazolin	O
interpretative	O
criteria	O
are	O
based	O
on	O
a	O
dosage	O
regimen	O
of	O
2g	O
every	O
8h.	O
SENSITIVITIES:	O
MIC	O
expressed	O
in	O
MCG/ML	O
_________________________________________________________	O
ESCHERICHIA	O
COLI	O
|	O
AMPICILLIN------------	O
<=2	O
S	O
AMPICILLIN/SULBACTAM--	O
<=2	O
S	O
CEFAZOLIN-------------	O
<=4	O
S	O
CEFEPIME--------------	O
<=1	O
S	O
CEFTAZIDIME-----------	O
<=1	O
S	O
CEFTRIAXONE-----------	O
<=1	O
S	O
CIPROFLOXACIN---------	O
=>4	O
R	O
GENTAMICIN------------	O
<=1	O
S	O
MEROPENEM-------------<=0.25	O
S	O
NITROFURANTOIN--------	O
<=16	O
S	O
PIPERACILLIN/TAZO-----	O
<=4	O
S	O
TOBRAMYCIN------------	O
<=1	O
S	O
TRIMETHOPRIM/SULFA----	O
=>16	O
R	O
___	O
11:00	O
am	O
BLOOD	O
CULTURE	O
**FINAL	O
REPORT	O
___	O
Blood	O
Culture,	O
Routine	O
(Final	O
___:	O
ESCHERICHIA	O
COLI.	O
FINAL	O
SENSITIVITIES.	O
Cefazolin	O
interpretative	O
criteria	O
are	O
based	O
on	O
a	O
dosage	O
regimen	O
of	O
2g	O
every	O
8h.	O
ESCHERICHIA	O
COLI.	O
___	O
MORPHOLOGY.	O
FINAL	O
SENSITIVITIES.	O
Cefazolin	O
interpretative	O
criteria	O
are	O
based	O
on	O
a	O
dosage	O
regimen	O
of	O
2g	O
every	O
8h.	O
SENSITIVITIES:	O
MIC	O
expressed	O
in	O
MCG/ML	O
_________________________________________________________	O
ESCHERICHIA	O
COLI	O
|	O
ESCHERICHIA	O
COLI	O
|	O
|	O
AMPICILLIN------------	O
<=2	O
S	O
<=2	O
S	O
AMPICILLIN/SULBACTAM--	O
<=2	O
S	O
<=2	O
S	O
CEFAZOLIN-------------	O
<=4	O
S	O
<=4	O
S	O
CEFEPIME--------------	O
<=1	O
S	O
<=1	O
S	O
CEFTAZIDIME-----------	O
<=1	O
S	O
<=1	O
S	O
CEFTRIAXONE-----------	O
<=1	O
S	O
<=1	O
S	O
CIPROFLOXACIN---------	O
=>4	O
R	O
=>4	O
R	O
GENTAMICIN------------	O
<=1	O
S	O
<=1	O
S	O
MEROPENEM-------------<=0.25	O
S	O
<=0.25	O
S	O
PIPERACILLIN/TAZO-----	O
<=4	O
S	O
<=4	O
S	O
TOBRAMYCIN------------	O
<=1	O
S	O
<=1	O
S	O
TRIMETHOPRIM/SULFA----	O
=>16	O
R	O
<=1	O
S	O
PERTINENT	O
IMAGING:	O
==================	O
___	O
MRI	O
C-spine:	O
1.	O
Examination	O
is	O
moderately	O
degraded	O
by	O
motion.	O
2.	O
Postsurgical	O
changes	O
of	O
laminectomies	O
from	O
C3-T1	O
with	O
marked	O
decrease	O
in	O
previously	O
noted	O
fluid	O
collection	O
at	O
the	O
surgical	O
site.	O
3.	O
Mild	O
anterolisthesis	O
of	O
C3	O
on	O
C4	O
and	O
minimal	O
anterolisthesis	O
of	O
C4	O
on	O
C5	O
and	O
C5	O
on	O
C6,	O
progressed	O
compared	O
to	O
prior	O
exam.	O
4.	O
Multilevel	O
posterior	O
disc	O
protrusions	O
and	O
moderate	O
to	O
severe	O
spinal	O
canal	O
narrowing	O
from	O
C3-C4	O
through	O
C5-C6,	O
most	O
severe	O
at	O
C5-C6	O
with	O
indentation	O
of	O
the	O
spinal	O
cord	O
and	O
mild	O
persistent	O
spinal	O
cord	O
edema,	O
improved	O
from	O
prior	O
exam.	O
5.	O
Unchanged	O
transverse	O
odontoid	O
fracture	O
at	O
the	O
base	O
with	O
distraction	O
and	O
posterior	O
angulation	O
of	O
the	O
odontoid	O
process.	O
6.	O
No	O
significant	O
spinal	O
canal	O
narrowing	O
in	O
the	O
thoracic	O
and	O
lumbar	O
spine.	O
7.	O
Postsurgical	O
changes	O
of	O
bilateral	O
laminectomies	O
at	O
L3	O
and	O
L4.	O
8.	O
L3-4	O
disc	O
protrusion	O
with	O
inferiorly	O
migrated	O
fragment	O
compressing	O
the	O
right	O
L4	O
nerve	O
root.	O
9.	O
Moderate	O
to	O
severe	O
multilevel	O
neural	O
foraminal	O
narrowing	O
in	O
the	O
lumbar	O
spine	O
on	O
the	O
right	O
at	O
L3-L4	O
and	O
bilaterally	O
at	O
L4-L5	O
and	O
L5-S1.	O
___	O
C-spine	O
single	O
view:	O
Status	O
post	O
anterior	O
C3	O
through	O
C6	O
cervical	O
fusion.	O
___	O
MRI	O
C-spine	O
w/o	O
Contrast:	O
1.	O
Status	O
post	O
new	O
ACDF	O
of	O
C3-C6.	O
2.	O
Central	O
cord	O
edema	O
from	O
C4-C7,	O
difficult	O
to	O
compare	O
with	O
motion	O
degraded	O
exam	O
from	O
___,	O
may	O
be	O
mildly	O
worsened	O
at	O
C5-C6,	O
with	O
suggestion	O
of	O
mild	O
cord	O
expansion.	O
3.	O
Moderate	O
to	O
severe	O
central	O
canal	O
narrowing	O
C5-C6	O
level,	O
mildly	O
improved.	O
4.	O
Moderate	O
central	O
canal	O
narrowing	O
C3-C4,	O
C4-C5	O
level,	O
mildly	O
improved.	O
5.	O
Multilevel	O
foraminal	O
narrowing.	O
6.	O
Odontoid	O
fracture,	O
stable.	O
7.	O
Multilevel	O
anterolisthesis,	O
stable.	O
___	O
Imaging	O
PERC	O
G/G-J	O
TUBE	O
PLMT	O
FINDINGS:	O
1.	O
Successful	O
placement	O
of	O
a	O
18	O
___	O
mic	O
gastrostomy	O
tube.	O
___	O
Imaging	O
VIDEO	O
OROPHARYNGEAL	O
SWA	O
FINDINGS:	O
There	O
is	O
aspiration	O
with	O
thin	O
and	O
nectar	O
thick	O
liquids.	O
IMPRESSION:	O
Aspiration	O
with	O
thin	O
and	O
nectar	O
thick	O
liquids.	O
Mr.	O
___	O
presents	O
with	O
severe	O
oropharyngeal	O
dysphagia	O
based	O
on	O
today's	O
video	O
swallow	O
study,	O
most	O
notable	O
for	O
reduced	O
oral	O
control/containment,	O
swallow	O
delay,	O
decreased	O
hyolaryngeal	O
movement,	O
impaired	O
pharyngeal	O
bolus	O
propulsion,	O
and	O
reduced	O
laryngeal	O
vestibular	O
closure.	O
There	O
was	O
silent	O
aspiration	O
of	O
thin	O
and	O
nectar-thick	O
liquids	O
as	O
well	O
as	O
deep	O
penetration	O
with	O
pudding.	O
There	O
were	O
no	O
swallowing	O
strategies	O
that	O
significantly	O
decreased	O
risk	O
of	O
aspiration.	O
It	O
is	O
unclear	O
at	O
this	O
time	O
how	O
much	O
of	O
pt's	O
current	O
swallow	O
function	O
is	O
consistent	O
with	O
baseline	O
vs.	O
acutely	O
worsened	O
function	O
s/p	O
cervical	O
ACDF	O
on	O
___.	O
Of	O
note,	O
the	O
patient's	O
mental	B-Delirium
status	B-Delirium
was	O
adequate	B-Delirium
and	O
appropriate	O
during	O
today's	O
study.	O
At	O
this	O
time,	O
there	O
is	O
no	O
safe	O
diet	O
without	O
high	O
risk	O
of	O
aspiration.	O
As	O
such,	O
recommend	O
NPO	O
status	O
at	O
this	O
time	O
to	O
optimize	O
safety.	O
Strongly	O
recommend	O
consideration	O
of	O
long-term	O
alternative	O
means	O
of	O
nutrition/hydration/medication	O
if	O
within	O
GOC.	O
Continue	O
with	O
short-term	O
NGT	O
pending	O
this	O
decision.	O
Pt	O
would	O
benefit	O
from	O
ongoing	O
swallowing	O
tx	O
here,	O
as	O
able,	O
and	O
at	O
rehab.	O
In	O
therapy	O
sessions,	O
___	O
may	O
provide	O
therapeutic	O
PO	O
of	O
___	O
tsp	O
of	O
nectar-thick	O
liquids	O
with	O
use	O
of	O
supraglottic	O
swallow	O
strategy.	O
Recommend	O
consideration	O
of	O
repeat	O
video	O
swallow	O
study	O
in	O
___	O
weeks	O
per	O
___	O
discretion	O
based	O
on	O
progress	O
in	O
therapy.	O
Given	O
unclear	O
chronicity	O
of	O
pt's	O
dysphagia,	O
prognosis	O
for	O
recovery	O
of	O
swallowing	O
function	O
is	O
not	O
entirely	O
clear	O
at	O
this	O
time;	O
however,	O
given	O
that	O
pt's	O
recent	O
ACDF	O
is	O
suspected	O
to	O
have	O
worsened	O
pt's	O
swallow	O
function,	O
there	O
is	O
certainly	O
a	O
possibility	O
that	O
pt's	O
swallowing	O
function	O
can	O
improve	O
with	O
increased	O
distance	O
from	O
this	O
surgery.	O
Our	O
service	O
will	O
continue	O
to	O
follow	O
for	O
ongoing	O
dysphagia	O
management	O
as	O
able.	O
Please	O
page	O
___	O
for	O
questions/concerns.	O
___BD	O
&	O
PELVIS	O
W/O	O
CON	O
1.	O
No	O
convincing	O
evidence	O
of	O
intra-abdominal	O
infectious	O
process	O
within	O
the	O
limitations	O
of	O
a	O
noncontrast	O
study.	O
2.	O
Status	O
post	O
bilateral	O
lower	O
quadrant	O
renal	O
transplant	O
with	O
mild	O
fullness	O
of	O
the	O
left	O
lower	O
quadrant	O
collecting	O
system	O
without	O
frank	O
hydronephrosis.	O
Fluid,	O
stranding	O
and	O
fascial	O
thickening	O
in	O
the	O
left	O
lower	O
abdomen	O
in	O
the	O
region	O
of	O
the	O
left	O
pelvic	O
transplant	O
raises	O
the	O
possibility	O
of	O
acute	O
pyelonephritis	B-Urinary_tract_infection
given	O
the	O
positive	O
urinalysis.	O
Evaluation	O
however	O
for	O
pyelonephritis	B-Urinary_tract_infection
is	O
not	O
possible	O
on	O
noncontrast	O
imaging.	O
3.	O
Small	O
bilateral	O
pleural	O
effusions.	O
___	O
Imaging	O
RENAL	O
TRANSPLANT	O
U.S.	O
Renal	O
transplant	O
without	O
evidence	O
of	O
hydronephrosis	O
or	O
obstruction.	O
Abnormal	O
main	O
renal	O
artery	O
waveform	O
with	O
good	O
systolic	O
flow	O
but	O
there	O
is	O
high	O
resistance	O
throughout	O
the	O
kidney.	O
RI	O
=	O
1.	O
DISCHARGE	O
LABS:	O
===============	O
___	O
07:28AM	O
BLOOD	O
WBC-6.3	O
RBC-2.51*	O
Hgb-7.9*	O
Hct-24.5*	O
MCV-98	O
MCH-31.5	O
MCHC-32.2	O
RDW-13.7	O
RDWSD-46.2	O
Plt	O
___	O
___	O
07:10AM	O
BLOOD	O
___	O
PTT-30.6	O
___	O
___	O
07:28AM	O
BLOOD	O
Glucose-140*	O
UreaN-23*	O
Creat-0.9	O
Na-143	O
K-4.0	O
Cl-108	O
HCO3-21*	O
AnGap-14	O
___	O
07:28AM	O
BLOOD	O
Calcium-8.3*	O
Phos-2.9	O
Mg-2.0	O
___	O
08:30AM	O
BLOOD	O
tacroFK-5.5	O
Brief	O
Hospital	O
Course:	O
Mr.	O
___	O
is	O
a	O
___	O
y/o	O
male	O
with	O
a	O
history	O
of	O
severe	O
cervical	O
stenosis	O
s/p	O
C3-C7	O
posterior	O
cervical	O
laminectomy/fusion	O
(___),	O
ESRD	O
s/p	O
renal	O
transplant	O
(___),	O
HTN,	O
DM,	O
seizures,	B-Seizures
and	O
OSA	O
who	O
presents	O
with	O
AMS	B-Delirium
and	O
weakness,	O
found	O
to	O
have	O
a	O
severe	O
cervical	O
cord	O
compression.	O
He	O
underwent	O
urgent	O
ACDF	O
of	O
C3-C6	O
on	O
___.	O
He	O
had	O
persistent	O
weakness	O
that	O
improved	O
slightly	O
during	O
the	O
hospitalization.	O
Hospital	O
course	O
was	O
complicated	O
by	O
dysphagia	O
s/p	O
G-tube	O
insertion,	O
urinary	O
retention,	O
E	O
coli	O
bacteremia,	O
pyelonephritis,	B-Urinary_tract_infection
___,	O
C	O
diff	O
colitis,	O
anemia,	O
and	O
delirium.	O
ACUTE	O
ISSUES	O
ADDRESSED	O
========================	O
#Cervical	O
cord	O
compression,	O
worst	O
at	O
C5-C6	O
#Cervical	O
stenosis	O
s/p	O
C3-C7	O
cervical	O
laminectomy	O
&	O
fusion	O
#S/p	O
ACDF	O
C3-C6	O
Patient	O
was	O
found	O
slumped	O
over,	O
unconsciousness	O
without	O
his	O
neck	O
brace	O
on	O
while	O
at	O
rehab.	O
After	O
regarding	O
consciousness,	O
he	O
had	O
acute	O
on	O
chronic	O
weakness,	O
particularly	O
over	O
the	O
BUE	O
that	O
was	O
associated	O
with	O
incontinence.	B-Urinary_incontinence
He	O
had	O
significant	O
diffuse	O
weakness	O
with	O
minimal	O
movement	O
of	O
his	O
fingers	O
and	O
___	O
strength	O
over	O
his	O
BLE.	O
He	O
was	O
placed	O
in	O
a	O
hard	O
collar	O
with	O
logroll	O
precautions.	O
MRI	O
spine	O
showed	O
multilevel	O
posterior	O
disc	O
protrusions	O
and	O
moderate	O
to	O
severe	O
spinal	O
canal	O
narrowing	O
from	O
C3-C4	O
through	O
C5-C6,	O
most	O
severe	O
at	O
C5-C6	O
with	O
indentation	O
of	O
the	O
spinal	O
cord.	O
He	O
underwent	O
urgent	O
ACDF	O
without	O
issues.	O
Repeat	O
MRI	O
done	O
due	O
to	O
persistent	O
weakness	O
showed	O
post-surgical	O
changes	O
without	O
worsening	O
cord	O
compression	O
or	O
fluid	O
collections.	O
Ortho	O
spine	O
felt	O
there	O
was	O
no	O
need	O
for	O
dexamethasone.	O
He	O
worked	O
with	O
___	O
who	O
recommended	O
d/c	O
with	O
continued	O
rehabilitation.	O
He	O
should	O
follow	O
up	O
with	O
Dr.	O
___	O
in	O
2	O
weeks	O
after	O
discharge.	O
#Acute	O
on	O
chronic	O
dysphagia	O
Previous	O
the	O
procedure,	O
the	O
patient	O
had	O
a	O
long	O
history	O
of	O
coughing	O
after	O
eating.	O
Following	O
the	O
ACDF,	O
the	O
patient	O
had	O
significant	O
trouble	O
swallowing,	O
noting	O
to	O
have	O
coughing	O
fits	O
and	O
trouble	O
swallowing	O
pills.	O
He	O
failed	O
multiple	O
speech	O
and	O
swallow	O
evaluations	O
in	O
a	O
row	O
including	O
video	O
swallow	O
study.	O
Etiology	O
was	O
initially	O
felt	O
to	O
be	O
due	O
to	O
post-operative	O
edema	O
impacting	O
his	O
pharyngeal	O
swallowing,	O
common	O
after	O
ACDF	O
and	O
generalizing	O
improves	O
with	O
time.	O
however	O
with	O
lack	O
of	O
improvement	O
during	O
prolonged	O
hospital	O
course,	O
there	O
may	O
a	O
component	O
of	O
worsening	O
chronic	O
dysphagia	O
I/s/o	O
cervical	O
spine	O
procedure.	O
He	O
was	O
placed	O
on	O
maintenance	O
IV	O
fluids,	O
given	O
tubefeeds	O
through	O
NGT	O
which	O
was	O
transitioned	O
to	O
G-tube	O
feeds.	O
The	O
patient	O
worked	O
with	O
speech	O
and	O
swallow	O
team	O
to	O
improve	O
swallowing	O
function	O
with	O
plans	O
to	O
continue	O
rehabilitation	O
with	O
goal	O
to	O
take	O
things	O
by	O
mouth	O
when	O
ready	O
with	O
removal	O
of	O
G-tube.	O
#E	O
coli	O
blood	O
stream	O
infection	O
#E	O
coli	O
pyelonephritis	B-Urinary_tract_infection
#Septic	O
shock:	O
#Leukocytosis:	O
Likely	O
___bdomen/pelvis	O
findings.	O
Blood	O
cultures	O
were	O
sensitive	O
to	O
cefepime	O
and	O
CTX.	O
He	O
was	O
initially	O
treated	O
with	O
cefepime	O
which	O
was	O
changed	O
to	O
ceftriaxone	O
that	O
was	O
changed	O
back	O
for	O
low	O
grade	O
fevers.	O
He	O
ultimately	O
finished	O
his	O
course	O
of	O
2	O
weeks	O
antibiotics	O
with	O
ceftriaxone.	O
Urine	O
culture	O
also	O
grew	O
pan-sensitive	O
e	O
coli.	O
#ESRD	O
s/p	O
renal	O
transplant	O
___	O
#Pyelnephritis	O
#Urinary	O
retention	O
with	O
obstruction	O
#CMV	O
detectable	O
viral	O
load	O
Cr	O
was	O
2.0	O
on	O
admission,	O
up	O
from	O
a	O
baseline	O
between	O
1.4-1.7.	O
He	O
was	O
given	O
intravenous	O
fluids	O
and	O
his	O
___	O
resolved.	O
His	O
home	O
prednisone	O
was	O
continued	O
and	O
his	O
tacrolimus	O
dose	O
was	O
decreased	O
from	O
1.5	O
mg	O
BID	O
to	O
0.5	O
mg	O
BID	O
due	O
to	O
an	O
elevated	O
level,	O
then	O
was	O
increased	O
to	O
1.0	O
QAM	O
and	O
0.5	O
QPM	O
for	O
therapeutic	O
goal	O
trough	O
level	O
of	O
___.	O
He	O
developed	O
___	O
during	O
admission	O
that	O
was	O
multifactorial	O
including	O
pre-renal	O
i/s/o	O
infection	O
(improved	O
with	O
IV	O
fluids),	O
pyelnephritis	O
as	O
noted	O
above,	O
and	O
post-renal	O
with	O
obstruction	O
(improved	O
with	O
foley	O
catheter,	O
stable	O
without	O
discontinuation	O
and	O
intemittent	O
straight	O
cath).	O
The	O
patient	O
had	O
detectable	O
viral	O
load	O
on	O
___	O
and	O
___	O
without	O
ongoing	O
evidence	O
of	O
end-organ	O
CMV	O
infection.	O
These	O
levels	O
were	O
drawn	O
I/s/o	O
low	O
grade	O
fevers,	O
which	O
resolved	O
without	O
anti-viral	O
medications.	O
We	O
would	O
recommend	O
f/u	O
on	O
this	O
and	O
treatment	O
as	O
appropriate.	O
The	O
patient	O
required	O
sodium	O
bicarbonate	O
to	O
reduce	O
acidemia	O
likely	O
___	O
to	O
renal	O
function.	O
Would	O
recommend	O
discontinuation	O
PRN.	O
#Urinary	O
retention	O
Developed	O
urinary	O
retention,	O
likely	O
from	O
a	O
component	O
of	O
cord	O
compression	O
with	O
possible	O
contribution	O
from	O
his	O
recent	O
surgery,	O
hospitalization,	O
and	O
opioids.	O
His	O
home	O
oxybutynin	O
was	O
held	O
and	O
he	O
underwent	O
intermittent	O
straight	O
catheterization.	O
His	O
urinary	O
retention	O
continued	O
throughout	O
the	O
hospitalization	O
and	O
at	O
discharge	O
intermittently.	O
#Severe	O
C	O
diff	O
colitis:	O
Patient	O
with	O
initial	O
C	O
diff	O
colitis	O
infection	O
with	O
severity	O
category	O
of	O
severe	O
given	O
peak	O
WBC	O
>15k	O
and	O
Creatinine	O
>=	O
1.5.	O
However,	O
determination	O
of	O
the	O
patient's	O
C	O
diff	O
severity	O
is	O
complicated	O
by	O
concurrent	O
E	O
coli	O
bloodstream	O
infection	O
and	O
pyelonephritis	B-Urinary_tract_infection
as	O
described	O
above.	O
He	O
was	O
treated	O
initially	O
with	O
IV	O
metronidazole	O
and	O
PO	O
vancomycin	O
125	O
QID	O
for	O
14	O
days	O
(___)	O
with	O
planned	O
maintenance	O
therapy	O
for	O
1	O
week	O
after	O
d/c-ing	O
other	O
antibiotics	O
(last	O
day	O
___.	O
His	O
IV	O
metronidazole	O
was	O
discontinued	O
after	O
resolution	O
of	O
leukocytosis	O
after	O
3	O
days.	O
#Syncope/AMS	O
Patient	O
was	O
found	O
to	O
be	O
unresponsive	O
and	O
slouched	O
over	O
in	O
a	O
chair	O
without	O
his	O
C-collar	O
in	O
place.	O
Unclear	O
if	O
he	O
had	O
true	O
syncope.	O
Differential	O
included	O
neurogenic	O
syncope	O
vs	O
seizure	B-Seizures
(particularly	O
given	O
history	O
of	O
seizures)	B-Seizures
vs	O
arrhythmia.	O
Stroke,	O
PE,	O
MI,	O
or	O
valvular	O
disease	O
were	O
felt	O
to	O
be	O
unlikely.	O
CT	O
head	O
was	O
negative	O
and	O
EKG	O
was	O
without	O
ischemia.	O
He	O
was	O
monitored	O
on	O
telemetry	O
without	O
arrhythmia	O
nor	O
recurrent	O
events.	O
#Delirium:	O
the	O
patient	O
experienced	O
delirium	B-Delirium
while	O
in	O
hospital	O
likely	O
related	O
to	O
toxic	O
metabolic	O
causes	O
(particularly	O
I/s/o	O
GNR	O
sepsis	O
and	O
septic	O
shock),	O
medication-induced	O
with	O
opioids.	O
He	O
was	O
treatd	O
with	O
high-dose	O
IV	O
thiamine	O
500mg	O
IV	O
TID	O
x	O
3d	O
(___)	O
in	O
case	O
of	O
refeeding	O
syndrome	O
and	O
Wernicke's	O
encephalopathy.	B-Delirium
Opioid	O
medications	O
were	O
discontinued.	O
#Anemia:	O
the	O
patient	O
had	O
downtrending	O
hgb	O
which	O
may	O
be	O
related	O
to	O
slow	O
GI	B-Lower_gastrointestinal_haemorrhage
bleed	B-Lower_gastrointestinal_haemorrhage
I/s/o	O
flexiseal	O
and	O
last	O
colonoscopy	O
on	O
record	O
with	O
5mm	O
benign	O
polyp	O
in	O
___	O
vs.	O
bone	O
marrow	O
suppression	O
in	O
acute	O
illness.	O
He	O
was	O
transfused	O
with	O
iron	O
with	O
increase	O
in	O
reticulocyte	O
count.	O
B12	O
and	O
folate	O
normal.	O
#DM	O
type	O
II,	O
insulin	O
dependent	O
Patient	O
on	O
NPH	O
at	O
home.	O
Initially,	O
his	O
home	O
NPH	O
was	O
held	O
given	O
low	O
BG	O
and	O
NPO	O
status.	O
His	O
insulin	O
regimen	O
was	O
adjusted	O
for	O
tubefeedings	O
with	O
BID	O
dosing	O
of	O
glargine	O
and	O
sliding	O
scale	O
Q6H	O
while	O
on	O
cycled	O
tube	O
feeds.	O
#Elevated	O
Troponin	O
Troponin	O
elevated	O
to	O
0.05	O
on	O
admission,	O
peaked	O
at	O
0.06	O
iso	O
renal	O
disease.	O
EKG	O
with	O
TWI	O
in	O
I,	O
otherwise	O
unremarkable.	O
He	O
remained	O
asymptomatic.	O
Felt	O
to	O
be	O
type	O
II	O
from	O
acute	O
illness.	O
He	O
was	O
continued	O
on	O
aspirin,	O
pravastatin,	O
and	O
carvedilol.	O
#Hyperkalemia	O
(resolved):	O
high	O
K	O
with	O
peaked	O
T	O
waves	O
in	O
V3	O
and	O
V4	O
more	O
so	O
than	O
prior.	O
High	O
potassium	O
may	O
be	O
related	O
to	O
poor	O
renal	O
clearance,	O
glucerna	O
tube	O
feeds,	O
and	O
neutraphos	O
standing	O
that	O
the	O
patient	O
was	O
getting.	O
He	O
was	O
treated	O
with	O
calcium	O
gluconate,	O
Lasix,	O
and	O
dext/insulin.	O
Potassium	O
levels	O
improved	O
with	O
changing	O
feeds	O
from	O
glucerna	O
to	O
nepro.	O
CHRONIC	O
CONDITIONS:	O
===================	O
#Hypertension:	O
Continued	O
amlodipine	O
10	O
mg	O
daily	O
and	O
carvedilol	O
6.25	O
mg	O
BID	O
#	O
Seizure	B-Seizures
disorder:	O
Continued	O
zonisamide	O
#	O
Restless	O
legs	O
syndrome:	O
Continued	O
ropinirole	O
#	O
Obstructive	O
sleep	O
apnea:	O
Not	O
on	O
CPAP	O
#	O
Depression/Anxiety:	O
Continued	O
escitalopram	O
and	O
quetiapine	O
#	O
GERD:	O
Continued	O
omeprazole	O
TRANSITIONAL	O
ISSUES:	O
===================	O
[]	O
ESRD	O
s/p	O
renal	O
transplant.	O
[]	O
CMV	O
viral	O
load	O
detectable	O
on	O
___	O
and	O
___	O
without	O
starting	O
medications.	O
We	O
recommend	O
f/u	O
CMV	O
viral	O
load	O
check	O
within	O
___	O
weeks	O
of	O
discharge	O
and	O
initiation	O
of	O
anti-viral	O
medications	O
PRN.	O
[]	O
Discharge	O
creatinine:	O
0.9	O
[]	O
Discharge	O
tacrolimus	O
trough	O
5.5	O
(for	O
goal	O
___	O
on	O
1	O
mg	O
PO	O
QAM	O
and	O
0.5	O
mg	O
QPM	O
(lowered	O
from	O
1.5	O
mg	O
BID)	O
[]	O
Acute	O
on	O
chronic	O
dysphagia:	O
continue	O
rehabilitation	O
work	O
with	O
speech	O
and	O
swallow	O
team.	O
Recommend	O
maximizing	O
PO	O
intake	O
when	O
safe	O
and	O
removal	O
of	O
G-tube	O
when	O
tolerating	O
PO	O
safely.	O
[]	O
C	O
diff	O
colitis:	O
patient	O
to	O
finish	O
7-day	O
post-CTX	O
PO	O
vancomycin	O
to	O
finish	O
C	O
diff	O
treatment.	O
[]	O
Anemia:	O
improved	O
retic	O
count	O
with	O
IV	O
iron	O
transfusion	O
x2.	O
Would	O
recommend	O
f/u	O
colonoscopy	O
as	O
outpatient	O
and	O
any	O
other	O
age-appropriate	O
cancer	O
screening.	O
[]	O
Acidemia:	O
the	O
patient	O
had	O
low	O
serum	O
bicarb	O
with	O
recommendation	O
for	O
supplementation	O
per	O
inpatient	O
renal	O
team.	O
Recheck	O
BMP	O
in	O
1	O
week	O
after	O
discharge	O
and	O
management	O
of	O
bicarb	O
supplementation	O
PRN	O
by	O
transplant	O
nephrology	O
team.	O
Greater	O
than	O
30	O
minutes	O
spent	O
on	O
complex	O
discharge	O
Medications	O
on	O
Admission:	O
The	O
Preadmission	O
Medication	O
list	O
is	O
accurate	O
and	O
complete.	O
1.	O
Acetaminophen	O
1000	O
mg	O
PO	O
Q8H	O
2.	O
amLODIPine	O
10	O
mg	O
PO	O
DAILY	O
3.	O
Escitalopram	O
Oxalate	O
10	O
mg	O
PO	O
DAILY	O
4.	O
Omeprazole	O
20	O
mg	O
PO	O
DAILY	O
5.	O
Pravastatin	O
20	O
mg	O
PO	O
QPM	O
6.	O
PredniSONE	O
5	O
mg	O
PO	O
DAILY	O
7.	O
rOPINIRole	O
4	O
mg	O
PO	O
QHS	O
8.	O
Zonisamide	O
200	O
mg	O
PO	O
BID	O
9.	O
Oxybutynin	O
10	O
mg	O
PO	O
DAILY	O
10.	O
LOPERamide	O
2	O
mg	O
PO	O
QID:PRN	O
diarrhea	O
11.	O
Sodium	O
Bicarbonate	O
650	O
mg	O
PO	O
BID	O
12.	O
Lidocaine	O
5%	O
Patch	O
1	O
PTCH	O
TD	O
QPM	O
13.	O
Aspirin	O
81	O
mg	O
PO	O
DAILY	O
14.	O
QUEtiapine	O
Fumarate	O
12.5	O
mg	O
PO	O
QHS:PRN	O
insomnia,	O
severe	O
agitation	O
15.	O
Polyethylene	O
Glycol	O
17	O
g	O
PO	O
DAILY:PRN	O
Constipation	B-Constipation
-	O
First	O
Line	O
16.	O
Tacrolimus	O
1.5	O
mg	O
PO	O
Q12H	O
17.	O
Bisacodyl	O
10	O
mg	O
PO/PR	O
DAILY	O
18.	O
Carvedilol	O
6.25	O
mg	O
PO	O
BID	O
19.	O
Breo	O
Ellipta	O
(fluticasone-vilanterol)	O
100-25	O
mcg/dose	O
inhalation	O
DAILY	O
asthma	O
20.	O
OxyCODONE	O
(Immediate	O
Release)	O
5	O
mg	O
PO	O
Q6H:PRN	O
Pain	O
-	O
Moderate	O
21.	O
NPH	O
16	O
Units	O
Breakfast	O
NPH	O
14	O
Units	O
Dinner	O
Discharge	O
Medications:	O
1.	O
Ascorbic	O
Acid	O
___	O
mg	O
PO	O
BID	O
Duration:	O
14	O
Days	O
2.	O
Chloraseptic	O
Throat	O
Spray	O
1	O
SPRY	O
PO	O
Q4H:PRN	O
throat	O
irritation	O
3.	O
Chlorhexidine	O
Gluconate	O
0.12%	O
Oral	O
Rinse	O
15	O
mL	O
ORAL	O
BID	O
4.	O
Gabapentin	O
300	O
mg	O
PO	O
TID	O
5.	O
Heparin	O
5000	O
UNIT	O
SC	O
BID	O
6.	O
Multivitamins	O
W/minerals	O
1	O
TAB	O
PO	O
DAILY	O
7.	O
Vancomycin	O
Oral	O
Liquid	O
___	O
mg	O
PO	O
QID	O
Duration:	O
7	O
Days	O
8.	O
Zinc	O
Sulfate	O
220	O
mg	O
PO	O
DAILY	O
Duration:	O
14	O
Days	O
9.	O
Glargine	O
10	O
Units	O
Breakfast	O
Glargine	O
10	O
Units	O
Bedtime	O
Insulin	O
SC	O
Sliding	O
Scale	O
using	O
REG	O
Insulin	O
10.	O
rOPINIRole	O
2	O
mg	O
PO	O
BID	O
11.	O
Tacrolimus	O
Suspension	O
1	O
mg	O
PO	O
QAM	O
12.	O
Tacrolimus	O
Suspension	O
0.5	O
mg	O
PO	O
QPM	O
13.	O
Acetaminophen	O
1000	O
mg	O
PO	O
Q8H	O
14.	O
amLODIPine	O
10	O
mg	O
PO	O
DAILY	O
15.	O
Aspirin	O
81	O
mg	O
PO	O
DAILY	O
16.	O
Breo	O
Ellipta	O
(fluticasone-vilanterol)	O
100-25	O
mcg/dose	O
inhalation	O
DAILY	O
asthma	O
17.	O
Carvedilol	O
6.25	O
mg	O
PO	O
BID	O
18.	O
Escitalopram	O
Oxalate	O
10	O
mg	O
PO	O
DAILY	O
19.	O
Lidocaine	O
5%	O
Patch	O
1	O
PTCH	O
TD	O
QPM	O
20.	O
Omeprazole	O
20	O
mg	O
PO	O
DAILY	O
21.	O
Pravastatin	O
20	O
mg	O
PO	O
QPM	O
22.	O
PredniSONE	O
5	O
mg	O
PO	O
DAILY	O
23.	O
QUEtiapine	O
Fumarate	O
12.5	O
mg	O
PO	O
QHS:PRN	O
insomnia,	O
severe	O
agitation	O
24.	O
Sodium	O
Bicarbonate	O
650	O
mg	O
PO	O
BID	O
25.	O
Zonisamide	O
200	O
mg	O
PO	O
BID	O
26.	O
HELD-	O
Bisacodyl	O
10	O
mg	O
PO/PR	O
DAILY	O
This	O
medication	O
was	O
held.	O
Do	O
not	O
restart	O
Bisacodyl	O
until	O
you	O
are	O
told	O
to	O
do	O
so	O
by	O
your	O
physician.	O
Discharge	O
Disposition:	O
Extended	O
Care	O
Facility:	O
___	O
Discharge	O
Diagnosis:	O
PRIMARY	O
DIAGNOSES	O
====================	O
Cervical	O
stenosis	O
s/p	O
C3-C7	O
cervical	O
laminectomy	O
&	O
fusion	O
Acute	O
cervical	O
cord	O
compression	O
s/p	O
ACDF	O
Dysphagia	O
E	O
coli	O
blood	O
stream	O
infection	O
Pyelonephritis	B-Urinary_tract_infection
C	O
diff	O
colitis	O
___	O
on	O
Chronic	O
kidney	O
disease	O
Delirium	B-Delirium
SECONDARY	O
DIAGNOSES	O
====================	O
Syncope	O
Diabetes	O
mellitus	O
type	O
II,	O
insulin	O
dependent	O
ESRD	O
s/p	O
renal	O
transplant	O
Elevated	O
troponin	O
Hypertension	O
Seizure	B-Seizures
disorder	O
Discharge	O
Condition:	O
Mental	B-Delirium
Status:	B-Delirium
Clear	B-Delirium
and	B-Delirium
coherent.	B-Delirium
Level	O
of	O
Consciousness:	O
Alert	O
and	O
interactive.	O
Activity	O
Status:	O
Bedbound.	B-Bed_Chairbound
Discharge	O
Instructions:	O
Dear	O
Mr.	O
___,	O
It	O
was	O
a	O
pleasure	O
caring	O
for	O
you	O
at	O
___	O
___.	O
Why	O
you	O
were	O
admitted	O
to	O
the	O
hospital:	O
-	O
You	O
were	O
found	O
unconsciousness,	O
and	O
then	O
with	O
new	O
significant	O
weakness.	O
What	O
happened	O
while	O
you	O
were	O
here:	O
-	O
Imaging	O
showed	O
worsening	O
compression	O
of	O
the	O
spinal	O
cord	O
in	O
your	O
neck,	O
causing	O
weakness	O
in	O
all	O
of	O
your	O
extremities	O
-	O
You	O
had	O
surgery	O
on	O
the	O
area	O
to	O
remove	O
the	O
compression	O
-	O
Following	O
the	O
procedure,	O
you	O
worked	O
with	O
physical	O
and	O
occupational	O
therapy	O
-	O
You	O
were	O
having	O
trouble	O
swallowing	O
and	O
was	O
found	O
to	O
be	O
aspirating	O
food	O
and	O
liquid.	O
You	O
got	O
tube	O
feeds	O
and	O
medications	O
through	O
nasogastric	O
tube	O
which	O
was	O
transitioned	O
to	O
a	O
G-tube.	O
-	O
You	O
had	O
a	O
blood	O
stream	O
infection,	O
transplanted	O
kidney	B-Urinary_tract_infection
infection,	B-Urinary_tract_infection
and	O
stool	O
infection	O
which	O
were	O
all	O
treated	O
with	O
antibiotics.	O
-	O
You	O
had	O
a	O
kidney	O
injury	O
which	O
was	O
treated	O
with	O
fluids,	O
antibiotics,	O
and	O
foley	O
insertion	O
for	O
urinary	O
retention.	O
-	O
You	O
were	O
having	O
problems	O
with	O
urinary	O
retention	O
and	O
needed	O
straight	O
catherizations	O
as	O
needed.	O
What	O
you	O
should	O
do	O
once	O
you	O
return	O
home:	O
-	O
Continue	O
taking	O
you	O
medications	O
as	O
prescribed	O
-	O
Please	O
follow	O
up	O
at	O
the	O
appointments	O
outlined	O
below	O
Sincerely,	O
Your	O
___	O
Care	O
Team	O
Followup	O
Instructions:	O
___	O

